Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The RAGE Gly82Ser polymorphism is not associated with cardiovascular disease in the Framingham offspring study.

Atherosclerosis - 1 Oct 2005

Hofmann Marion A, Yang Qiong, Harja Evis, Kedia Prashant, Gregersen Peter K, Cupples L Adrienne, Schmidt Ann Marie, Hudson Barry I

Abstract excerpt

The receptor for advanced glycation end-products (RAGE) is expressed to enhance degrees in human atherosclerotic plaques and co-localizes with inflammatory and pro-oxidant mediators in the vulnerable regions of the plaque. Previous studies highlighted a number of variants in the gene encoding the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiovascular Diseases
Share to Cohort Studies
Share to Incidence

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Massachusetts

Share to Polymorphism, Genetic

Share to Prevalence

Share to Receptor for Advanced Glycation End Products

Share to Receptors, Immunologic

Source

Identifiers

PMID: 16159602
DOI: 10.1016/j.atherosclerosis.2005.02.006

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-16159602-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The RAGE Gly82Ser polymorphism is not associated with cardiovascular disease in the Framingham offspring study.PMID 16159602Read ↗

The Gly82Ser polymorphism in the receptor for advanced glycation endproducts increases the risk for coronary events in the general population.Semantic proximity Read ↗

Association of RAGE gene Gly82Ser polymorphism with coronary artery disease and ischemic stroke: A systematic review and meta-analysis.Semantic proximity Read ↗

Receptor for advanced glycation end products Glycine 82 Serine polymorphism and risk of cardiovascular events in rheumatoid arthritis.Semantic proximity Read ↗

Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and nonobese Koreans.Semantic proximity Read ↗

Association between the receptor for advanced glycation end products gene polymorphisms and coronary artery disease.Semantic proximity Read ↗

The Gly82Ser polymorphism of the receptor of advanced glycation end product (RAGE) gene is not associated with type 1 or type 2 diabetes in a Brazilian population.Semantic proximity Read ↗

Association of polymorphisms in the RAGE gene with serum CRP levels and coronary artery disease in the Chinese Han population.Semantic proximity Read ↗

Association of polymorphisms of the receptor for advanced glycation end products gene and susceptibility to sporadic abdominal aortic aneurysm.Semantic proximity Read ↗

Pathological Implications of Receptor for Advanced Glycation End-Product (AGER) Gene PolymorphismSemantic proximity Read ↗

Meta-analysis of RAGE gene polymorphism and coronary heart disease risk.Semantic proximity Read ↗

Is there any association between GLY82 ser polymorphism of rage gene and Turkish diabetic and non diabetic patients with coronary artery disease?Semantic proximity Read ↗

Association of the RAGE G82S polymorphism with Alzheimer's disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.